Immediate type hypersensitivity to chemotherapeutic agents in pediatric patients

Asian Pacific Journal of Allergy and Immunology

Volumn 27, Issue 4, 2009, Pages 191-197

  Visitsunthorn, Nualanong ^a   Utsawapreechawong, Wipa ^a   Pacharn, Punchama ^a   Jirapongsananuruk, Orathai ^a   Vichyanond, Pakit ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MESNA; VINCRISTINE;

ABDOMINAL PAIN; ADOLESCENT; ANAPHYLAXIS; ARTICLE; CHEST TIGHTNESS; CHILD; CLINICAL ARTICLE; DESENSITIZATION; DISEASE COURSE; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG RECHALLENGE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLIOMA; HUMAN; HYPOTENSION; IMMEDIATE TYPE HYPERSENSITIVITY; INJECTION SITE URTICARIA; INTRACUTANEOUS TEST; LYMPHATIC LEUKEMIA; MALE; NAUSEA; OLIGODENDROGLIOMA; PRESCHOOL CHILD; PURE RED CELL ANEMIA; SCHOOL CHILD; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; URTICARIA; VOMITING; ACUTE LYMPHOBLASTIC LEUKEMIA; CENTRAL NERVOUS SYSTEM TUMOR; CHEMICALLY INDUCED DISORDER; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; SKIN TEST; TREATMENT WITHDRAWAL;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ASPARAGINASE; CARBOPLATIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; GLIOMA; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MESNA; PRACTICE GUIDELINES AS TOPIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SKIN TESTS; VINCRISTINE; WITHHOLDING TREATMENT;

EID: 77953647798     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lenz HJ. Management and preparedness for infusion and hypersensitivity reactions. Oncologist 2007; 12: 601-9.
2. Shepherd GM. Hypersensitivity reactions to chemotherapeutic drugs. Clin Rev Allergy Immunol 2003; 24: 253-62.
3. Markman M, Kennedy A, Webster K, et al. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol 1999; 17: 1141-5.
4. Dizon DS, Sabbatini PJ, Aghajanian C, Hensley ML, Spriggs DR. Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy. Gynecol Oncol 2002; 84: 378-82.
5. Zweizig S, Roman LD, Muderspach LI. Death from anaphylaxis to cisplatin: a case report. Gynecol Oncol 1994; 53: 121-2.
6. Santini D, Tonini G, Salerno A, et al. Idiosyncratic reaction after oxaliplatin infusion. Ann Oncol 2001; 12: 132-3.
7. Thomas RR, Quinn MG, Schuler B, Grem JL. Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer 2003; 97: 2301-7.
8. Zanotti KM, Markman M. Prevention and management of antineoplastic-induced hypersensitivity reactions. Drug Saf 2001; 24: 767-79.
9. Maindrault-Goebel F, André T, Tournigand C, et al. Allergic-type reactions to oxaliplatin. Eur J Cancer 2005; 41: 2262-7.
10. Petit-Laurent F, Conroy T, Krakowski I, Barbaud A, Trechot P. Delayed urticaria with oxaliplatin. Gastroenterol Clin Biol 2000; 24: 851-2.
11. Weidmann B, Mülleneisen N, Bojko P, Niederle N. Hyper-sensitivity reactions to carboplatin: Report of two patients, review of the literature, and discussion of diagnostic procedures and management. Cancer 1994; 73: 2218-22.
12. Chang SM, Fryberger S, Crouse V, Tilford D, Prados MD. Carboplatin hypersensitivity in children. A report of 5 patients with brain tumors. Cancer 1995; 75: 1171-5.
13. Kook H, Kim KM, Choi SH, et al. Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization. Bone Marrow Transplant 1998; 21: 727-9.
14. Sood AK, Gelder MS, Huang SW, Morgan LS. Anaphylaxis to carboplatin following multiple previous uncomplicated courses. Gynecol Oncol 1995; 57: 131-2.
15. de Shazo RD, Kemp SF. Allergic reactions to drugs and biologic agents. JAMA 1997; 278: 1895-906.
16. Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008; 100: S1-148.
17. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report: Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphy-laxis Network Symposium. J Allergy Clin Immunol 2006; 117: 391-7.
18. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005; 115: S483-523.
19. Popescu NA, Sheehan MG, Kouides PA, et al. Allergic reactions to cyclophosphamide: Delayed clinical expression associated with positive immediate skin tests to drug meta-bolites in five patients. J Allergy Clin Immunol 1996; 97: 26-33.
20. Lee CW, Matulonis UA, Castells MC. Carboplatin hyper-sensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol 2004; 95: 370-6.
21. Sliesoraitis S, Chikhale PJ. Carboplatin hypersensitivity. Int J Gynecol Cancer 2005; 15: 13-8.
22. Zanotti KM, Rybicki LA, Kennedy AW, et al. Carboplatin skin testing: a skin-testing protocol for predicting hypersen-sitivity to carboplatin chemotherapy. J Clin Oncol 2001; 19: 3126-9.
23. Markman M, Zanotti K, Peterson G, Kulp B, Webster K, Belinson J. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol 2003; 21: 4611-4.
24. Castells M C. Drug desensitization in oncology: chemotherapy agents and monoclonal antibodies. In: Pichler WJ, ed. Drug hypersensitivity. New York: Karger 2007; pp. 413-25.
25. Castells M. Rapid desensitization of hypersensitivity reactions to chemotherapy agents. Curr Drug Saf. 2006; 1: 243-51.
26. Menczer J, Barda G, Glezerman M, et al. Hypersensitivity reaction to carboplatin. Results of skin tests. Eur J Gynaecol Oncol 1999; 20: 214-6.
27. Garufi C, Cristaudo A, Vanni B, et al. Skin testing and hypersensitivity reactions to oxaliplatin. Ann Oncol 2003; 14: 497-8.
28. Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008; 122: 574-80.
29. Soyer OU, Aytac S, Tuncer A, Cetin M, Yetgin S, Sekerel BE. Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia. J Allergy Clin Immunol 2009; 123: 895-9.
30. Gonzalez ID, Saez RS, Rodila EM, Yges EL, Toledano FL. Hypersensitivity reactions to chemotherapy drugs. Alergol Inmunol Clin 2000; 15: 161-81.
31. Rosas-Vargas MA, Casas-Becerra B, Velazquez-Armenta Y, Sienra-Monge JL, Del Rio-Navarro BE. Cyclophosphamide hypersensitivity in a leukemic child. Ther Drug Monit 2005; 27: 263-4.